XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Operating activities              
Net loss $ (1,760) $ (2,953) $ (1,504) $ (1,657) $ (6,000) $ (4,370)  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation         4,735 4,670  
Amortization of intangible assets         2,420 965  
Provision for bad debt, net         (29) 113  
Stock-based compensation         382 416  
Gain on disposal of discontinued operations         0 (350)  
Amortization of loan issuance costs         248 48  
Debt issuance costs write-off 0   0   0 151  
Financing costs write-off         0 273  
Loss (Gain) on sale of assets         142 (56)  
Deferred income taxes, net         68 (75)  
Other, net         (33) (29)  
Changes in operating assets and liabilities:              
Accounts receivable         2,850 (1,380)  
Inventories         (1,735) (1,081)  
Other assets         (852) (506)  
Accounts payable         (2,109) 242  
Accrued compensation         (845) (267)  
Deferred revenue         494 142  
Operating lease liabilities         (12) (46)  
Other liabilities         (1,604) 375  
Net cash used in operating activities         (1,880) (765)  
Investing activities              
Purchases of property and equipment         (646) (1,182)  
Purchase of real estate from related and third parties         0 (5,180)  
Proceeds from sale of property and equipment         156 1,496  
Proceeds from sales of equity securities         0 140  
Payments to acquire interest in joint ventures         0 (1,000)  
Net cash used in investing activities         (490) (5,726)  
Financing activities              
Proceeds from borrowings         85,648 66,640  
Repayment of debt         (84,940) (59,057)  
Repayment of Gerber acquisition loan         0 (3,000)  
Loan issuance costs         (317) (421)  
Net proceeds from sale of common stock and warrants         4,203 0  
Proceeds from exercise of over-allotment options and warrants         892 0  
Proceeds from issuance of preferred stock         0 3,000  
Fees paid on issuance of preferred stock         (3) (150)  
Taxes paid related to net share settlement of equity awards         (13) (24)  
Repayment of obligations under finance leases         (725) (626)  
Net cash provided by financing activities         4,745 6,362  
Net increase (decrease) in cash, cash equivalents, and restricted cash         2,375 (129)  
Cash, cash equivalents, and restricted cash at beginning of period   $ 2,061   $ 1,802 2,061 1,802 $ 1,802
Cash, cash equivalents, and restricted cash at end of period $ 4,436   $ 1,673   $ 4,436 $ 1,673 $ 2,061